Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantation Research (CIBMTR) and the Pediatric Health Information System (PHIS)

Caitlin W Elgarten, MD MSc, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Richard Aplenc, MD PhD, Michael T. Hemmer, MS, Mukta Arora, MD, Stephen R. Spellman, MS, Tao Wang, PhD, Madan Jagasia, MBBS, MS, MMHC, Margaret L. MacMillan, MD, Joseph Pidala, MD, Brian T. Fisher, DO, MSCE, Matt Hall, PhD

Blood (2019) 134 (Supplement_1): 599.

https://doi.org/10.1182/blood-2019-130466

Published: 2019

Journal Articles

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Razan Mohty, MD, Remy Dulery, MD, Giorgia Battipaglia, MD, Eolia Brissot, MD PhD, Clemence Mediavilla, MD, Simona Sestili, MD, Tounes Ledraa, MD, Béatrice Gaugler, PhD, Agnès Bonnin, Mohamad Mohty, MD PhD, Florent Malard, MD PhD

Blood (2019) 134 (Supplement_1): 4539.

https://doi.org/10.1182/blood-2019-125213

Published: 2019

Journal Articles

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Jessica Caro, MD, Erin Moshier, MS, Douglas Tremblay, MD, Alexander Coltoff, MD, Guido Lancman, MD, Meenakshi Rana, MD, John Mascarenhas, MD, Samantha Jacobs, MD

Blood (2019) 134 (Supplement_1): 3849.

https://doi.org/10.1182/blood-2019-123435

Published: 2019

Journal Articles

Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies

Caitlin Siebenaller, PharmD, Madeline Waldron, PharmD, BCOP, Kelly Gaffney, PharmD, Brian P. Hobbs, PhD, Ran Zhao, Marc Earl, PharmD, Marina Feldman, PharmD, BCCCP, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, MD, Aaron T. Gerds, MD MS, Bhumika J. Patel, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2019) 134 (Supplement_1): 3433.

https://doi.org/10.1182/blood-2019-128807

Published: 2019

Journal Articles

Severe Infections and Antibiotic Use Negatively Impact Progression Free and Overall Survival of Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Marshall McKenna, MD, Rena Feinman, PhD, Jaeil Ahn, PhD, Shuqi Wang, MSc, Elli Gourna Paleoudis, PhD, David H. Vesole, MD PhD, Stuart L. Goldberg, MD, Jun Chih Wang, MD, Abdul Rehman, MD, Giselle Alexandra Suero-Abreu, MD PhD, Phyllis McKiernan, Michele L. Donato, MD, Scott D. Rowley, MD, David S. Siegel, Noa Biran, MD

Blood (2019) 134 (Supplement_1): 5510.

https://doi.org/10.1182/blood-2019-132134

Published: 2019

Journal Articles

Cumulative Incidence of Blood Stream Infections during Acute Myeloid Leukemia Treatment in the Netherlands: A 15-Year Overview

Emily Risa Schwartz, Sc.B., A.B., Kim Klein, MD MSc, Valerie de Haas, MD PhD, Birgit Lissenberg-Witte, PhD, Lynn Ball, MD, Natasja Dors, MD, Marry M Van den Heuvel-Eibrink, Prof, MD PhD, Rutger Knops, MD, Wim Tissing, MD, Birgitta A. Versluys, MD PhD, Christian M. Zwaan, MD, Raphaele R.L. van Litsenburg, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2018) 132 (Supplement 1): 2685.

https://doi.org/10.1182/blood-2018-99-114364

Published: 2018

Journal Articles

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

Kyle Grose, PharmD, Karen K. Ballen, MD, Tamila L Kindwall-Keller, DO, Kathlene DeGregory, PharmD, BCOP, Gina Petroni, PhD, Gerald R. Donowitz, MD, Brian Wispelwey, MD, Costi Sifri, MD, Leonid Volodin, MD

Blood (2018) 132 (Supplement 1): 3435.

https://doi.org/10.1182/blood-2018-99-111990

Published: 2018

Journal Articles

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

Tatsuya Suwabe, MD, Kyoko Fuse, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD PhD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5712.

https://doi.org/10.1182/blood-2018-99-115844

Published: 2018

Journal Articles

Risk Factors of Clostridium Difficile Infection in Hematopoietic Stem Cell Transplant Recipients: A Systemic Review and Meta-Analysis

Raseen Tariq, MBBS, Fateeha Furqan, MD, Saad Jamshed, MD, Sahil Khanna, MBBS

Blood (2018) 132 (Supplement 1): 4704.

https://doi.org/10.1182/blood-2018-99-114231

Published: 2018

Journal Articles

Impact of Omitting Prophylactic Antibiotics, to Preserve Gut Microbiota, on the Incidence of Bacteraemia during the Pre-Engraftment Period of Allogenic Hematopoietic Stem Cell Transplantation

Claudie Roy, MD, Simon Frédéric Dufresne, MD FRCP, Miguel Chagnon, M.Sc, P.Stat, Silvy Lachance, MD FRCP

Blood (2018) 132 (Supplement 1): 2094.

https://doi.org/10.1182/blood-2018-99-119525

Published: 2018

Journal Articles

Differences in Infection Prophylaxis between Pediatric AML Study Groups within the International BFM Study Group

Kim Klein, MD MSc, Henrik Hasle, MD PhD, Jonas Abrahamsson, MD PhD, Barbara De Moerloose, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2017) 130 (Supplement 1): 2104.

https://doi.org/10.1182/blood.V130.Suppl_1.2104.2104

Published: 2017

Journal Articles

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Marla M. Jalbut, MD, Evan C. Chen, MD, Gabriela S. Hobbs, MD, Ashley M. Perry, BS, Lillian Werner, MS, Philip C. Amrein, MD, Amir T. Fathi, MD MD BS, Andrew M. Brunner, MD

Blood (2017) 130 (Supplement 1): 2586.

https://doi.org/10.1182/blood.V130.Suppl_1.2586.2586

Published: 2017

Journal Articles

A Comparison of Levofloxacin and Oral Third Generation Cephalosporins As Antibacterial Prophylaxis in Acute Myeloid Leukemia (AML) during Chemotherapy-Induced Neutropenia

Kristyn E. Yemm, PharmD, Jason N. Barreto, PharmD, Ross A. Dierkhising, MS, Kristin C. Mara, MS, Naseema Gangat, MBBS, Pritish K. Tosh, MD

Blood (2016) 128 (22): 3986.

https://doi.org/10.1182/blood.V128.22.3986.3986

Published: 2016

Journal Articles

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Benedetta Rambaldi, MD, Michele Malagola, MD PhD, Giuseppe Ravizzola, MD, Giorgio Giannetta, Nicola Polverelli, MD PhDstudent, Cristina Skert, MD, Alessandro Turra, MD, Valeria Cancelli, MD, Federica Cattina, MD PhD, Francesca Schieppati, MD, Arnaldo Caruso, MD, Domenico Russo, MD

Blood (2016) 128 (22): 2223.

https://doi.org/10.1182/blood.V128.22.2223.2223

Published: 2016

Journal Articles

Effectiveness of Antibacterial Prophylaxis during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

Maria Luisa Sulis, MD, Traci M. Blonquist, MS, Uma H. Athale, MD, M.Sc., Luis A. Clavell, MD, Peter D. Cole, MD, Kara M. Kelly, MD, Caroline Laverdiere, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Donna S Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2015) 126 (23): 249.

https://doi.org/10.1182/blood.V126.23.249.249

Published: 2015

Journal Articles

A Subgroup Analysis of Patients Undergoing Autologous and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Deflect-1: A Double-Blind, Randomized Study of Fidaxomicin Vs. Placebo for Prophylaxis Against C. Difficile Infection

Michael J Dugan, MD, Drew Winston, MD, Michele I Morris, MD, James E Williams, MD, Natasha Broyde, MS, Pamela Sears, PhD

Blood (2015) 126 (23): 390.

https://doi.org/10.1182/blood.V126.23.390.390

Published: 2015

Journal Articles

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

Enrico Maria Trecarichi, MD, Mario Tumbarello, MD, Roberta Di Blasi, MD, Luana Fianchi, Simona Sica, Bruno Martino, MD, Anna Candoni, MD, Gianpaolo Nadali, MD, Domenico Pastore, Vincenzo Perriello, MD, Alessandro Busca, MD, Franco Aversa, MD, Rosa Fanci, MD, Lorella Melillo, MD, Federica Lessi, MD, Maria Ilaria Del Principe, MD, Chiara Cattaneo, Livio Pagano

Blood (2015) 126 (23): 3757.

https://doi.org/10.1182/blood.V126.23.3757.3757

Published: 2015

Journal Articles

Influence of Prophylactic Antibiotics Aiming at Gut Decontamination on Gastrointestinal Graft-Versus-Host Disease and Overall Survival Following Allogeneic Haematopoietic Stem Cell Transplantation

Bertrand Routy, MD, Caroline Letendre, MD, Maxime Chenard-Poirier, MD, Vikram Mehraj, PhD, David Enot, Khaled Guenda, MD, Noemie Charbonneau Séguin, Kathia Gagnon, Silvy Lachance, MD

Blood (2015) 126 (23): 4319.

https://doi.org/10.1182/blood.V126.23.4319.4319

Published: 2015

Journal Articles

Necrobiotic Xanthogranuloma (NXG) Associated with Monoclonal Gammopathies (MG): Clinical Features and Treatment Outcomes

Larissa Higgins, MD, Ronald S. Go, MD, Shaji Kumar, MD, S. Vincent Rajkumar, Francis Buadi, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, David Dingli, MD PhD FRCP, John A. Lust, MD PhD, Prashant Kapoor, MD, Robert A. Kyle, MD, Morie A. Gertz, MD, Wilson I. Gonsalves, MD

Blood (2015) 126 (23): 1830.

https://doi.org/10.1182/blood.V126.23.1830.1830

Published: 2015

Journal Articles

Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies

Katsuhiro Miura, MD, Satomi Kiso, MD, Masaru Nakagawa, MD, Hiromichi Takahashi, MD PhD, Yoshito Uchino, MD, Hitomi Kodaira, MD, Noriyoshi Iriyama, MD PhD, Masashi Sakagami, MD, Shimon Ohtake, MD, Sumiko Kobayashi, MD PhD, Atsuko Hojo, MD, Mai Yagi, MD, Daisuke Kurita, MD, Yujin Kobayashi, MD PhD, Machiko Kusuda, MD, Yukio Hirabayashi, MD PhD, Yoshihiro Hatta, MD PhD, Masami Takei, MD PhD

Blood (2014) 124 (21): 3674.

https://doi.org/10.1182/blood.V124.21.3674.3674

Published: 2014

NARROW

Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantation Research (CIBMTR) and the Pediatric Health Information System (PHIS)

Investigating Antibiotic Exposure and Risk of Severe Acute Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Primary Antibacterial Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients

Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies

Severe Infections and Antibiotic Use Negatively Impact Progression Free and Overall Survival of Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Cumulative Incidence of Blood Stream Infections during Acute Myeloid Leukemia Treatment in the Netherlands: A 15-Year Overview

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

Risk Factors of Clostridium Difficile Infection in Hematopoietic Stem Cell Transplant Recipients: A Systemic Review and Meta-Analysis

Impact of Omitting Prophylactic Antibiotics, to Preserve Gut Microbiota, on the Incidence of Bacteraemia during the Pre-Engraftment Period of Allogenic Hematopoietic Stem Cell Transplantation

Differences in Infection Prophylaxis between Pediatric AML Study Groups within the International BFM Study Group

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

A Comparison of Levofloxacin and Oral Third Generation Cephalosporins As Antibacterial Prophylaxis in Acute Myeloid Leukemia (AML) during Chemotherapy-Induced Neutropenia

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Effectiveness of Antibacterial Prophylaxis during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

A Subgroup Analysis of Patients Undergoing Autologous and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Deflect-1: A Double-Blind, Randomized Study of Fidaxomicin Vs. Placebo for Prophylaxis Against C. Difficile Infection

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

Influence of Prophylactic Antibiotics Aiming at Gut Decontamination on Gastrointestinal Graft-Versus-Host Disease and Overall Survival Following Allogeneic Haematopoietic Stem Cell Transplantation

Necrobiotic Xanthogranuloma (NXG) Associated with Monoclonal Gammopathies (MG): Clinical Features and Treatment Outcomes

Clinical Significance of Arbekacin Sulfate for High-Risk Infections Among Patients with Hematological Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only